NHC NATIONAL HEALTHCARE CORP Insider Trading

Director Lisa Piercey initiates stake in NHC: 949 shares at $184.26 (post-transaction: 949 shares)

Lisa Piercey, a Director, purchased 949 shares of National Healthcare Corp on June 1, 2026, at $184.26 per share for a total value of $174,858.85, establishing an initial shareholding position. The transaction occurs with NHC trading at $183.35 currently, near its 52-week midpoint after a +4.9% gain over 30 days and +6.1% over 90 days, while the stock remains -10.6% from its 52-week high of $205.06. The company displays solid fundamentals: latest quarterly revenue of $381,821,000.00 with net income of $35,857,000.00, annual growth of +16.1%, and a reasonable P/E of 23.15 on a market cap of $2,863,861,177.35. A director's initiation of a new shareholding position warrants attention, though the significance is moderated by the relatively modest dollar amount and absence of prior trading history context at this ticker.

Director Richard F Jr Laroche sold 7,500 NHC shares at $195.14 on 2026-05-21 for $1,463,565.75; retained 205,760 shares post-sale.

Richard F Jr Laroche, a director at National Healthcare Corp, sold 7,500 shares (3.5% of his pre-transaction holdings) at $195.14, reducing his stake to 205,760 shares. The sale occurred near the 52-week high of $205.06, with the stock currently trading at $195.41, down 4.7% from that peak. While his cross-ticker track record shows only 1 prior buy with no timing data yet available, his same-ticker history at NHC shows one prior purchase on 2023-06-29 whose outcome remains unmeasurable. The modest position reduction occurs within the context of the company's strong fundamentals—annual revenue growth of 16.1% and a market cap of $3.1B—though the company trades at a P/E of 24.67.